More details of a proposed $11 million-a-year ‘Neovascular AMD treatment incentive program’ that would financially encourage more ophthalmologists to bulk...
Read moreDetailsPeople living in the east of Perth’s vast metropolitan area have little or no access to public eyecare services, resulting...
Read moreDetailsAlexion, AstraZeneca rare disease treatment Ultomiris (ravulizumab rch) has become the first targeted treatment option to be reimbursed for people living...
Read moreDetailsMalaysia has banned the online sale of contact lenses and optical devices on e-commerce platforms. According to the New Straits Times...
Read moreDetailsAbolishment of non-compete clauses for employees, new investments in public hospitals and cheaper government-subsidised medicines are among the 2025/26 Federal...
Read moreDetailsOptometry Australia (OA) is intensifying its election campaign following what it calls “underwhelming responses” from key political parties, warning that...
Read moreDetailsMedical professionals working past the age of 70 are a small portion of the sector but apparently attract more than...
Read moreDetailsThe Government’s Aged Care Act 2024 is a welcome commitment to the country’s older citizens, but a lack of clarity...
Read moreDetailsA nonprofit trade association for manufacturers and suppliers of the optical industry in the United States believes that trade tariffs kicked...
Read moreDetailsOptometry Australia says it is working with all private health funds towards standardisation, as practices continue to navigate a “minefield”...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited